近日，博澤格霖（山東）藥業(yè)有限公司的原料藥產(chǎn)品噻托溴銨收到歐洲藥品質(zhì)量管理局（EDQM）頒發(fā)的原料藥歐洲藥典適用性證書（簡稱CEP證書），這也是公司獲批的第三個(gè)CEP證書。
噻托溴銨是長效抗膽堿能藥物，用于成人慢性阻塞性肺疾病（COPD）的維持治療。
博澤格霖深耕吸入制劑用原料藥領(lǐng)域，可供應(yīng)全品系吸入原料及粉體定制化服務(wù)，始終以“國際化品質(zhì)” 為核心戰(zhàn)略；目前，公司產(chǎn)品已獲中國、歐洲、日本等主流市場批準(zhǔn)，為制劑客戶提供更廣闊的市場布局支持。
未來，公司將持續(xù)精進(jìn)技術(shù)與服務(wù)，堅(jiān)守國際標(biāo)準(zhǔn)，穩(wěn)定供應(yīng)高品質(zhì)原料藥，與全球制劑企業(yè)攜手拓展國際市場，豐富優(yōu)質(zhì)用藥選擇。
Great News! Our Tiotropium Bromide API Has Obtained the CEP Certificate!
Recently, our API Product active pharmaceutical ingredient (API) Tiotropium Bromide Monohydrate has been granted the Certificate of Suitablility to the European Pharmacopoeia (CEP) by the European Directorate for the Quality of Medicines & HealthCare (EDQM). This is the third CEP certificate obtained by our company.
Tiotropium Bromide is a long-acting anticholinergic agent indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults.
Breathgreen Pharm specializes in powder Property manipulation for pharmaceutical products , offering all respiratory therapy used API and customized powder processing services. Upholding "international quality" as our core strategy, our products have been approved in key markets including China, Europe, and Japan, supporting formulation customers in broader global market expansion.
Moving forward, we will continue to advance our technology and services, adhere to international standards, and ensure a stable supply of high-quality APIs. We look forward to partnering with global formulation companies to expand internationally and enrich the selection of high-quality medications.
